Search

Your search keyword '"Ruiz-Camps, Isabel"' showing total 3 results
Start Over Author "Ruiz-Camps, Isabel" Journal antimicrobial agents and chemotherapy
3 results on '"Ruiz-Camps, Isabel"'

1. Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia

Author

Gudiol, Carlota, primary, Royo-Cebrecos, Cristina, additional, Abdala, Edson, additional, Akova, Murat, additional, Álvarez, Rocío, additional, Maestro-de la Calle, Guillermo, additional, Cano, Angela, additional, Cervera, Carlos, additional, Clemente, Wanessa T., additional, Martín-Dávila, Pilar, additional, Freifeld, Alison, additional, Gómez, Lucía, additional, Gottlieb, Thomas, additional, Gurguí, Mercè, additional, Herrera, Fabián, additional, Manzur, Adriana, additional, Maschmeyer, Georg, additional, Meije, Yolanda, additional, Montejo, Miguel, additional, Peghin, Maddalena, additional, Rodríguez-Baño, Jesús, additional, Ruiz-Camps, Isabel, additional, Sukiennik, Teresa C., additional, Tebe, Cristian, additional, and Carratalà, Jordi, additional

Published
2017
Full Text
View/download PDF

3. Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceaein Hematological Patients with Neutropenia

Author

Gudiol, Carlota, Royo-Cebrecos, Cristina, Abdala, Edson, Akova, Murat, Álvarez, Rocío, Maestro-de la Calle, Guillermo, Cano, Angela, Cervera, Carlos, Clemente, Wanessa T., Martín-Dávila, Pilar, Freifeld, Alison, Gómez, Lucía, Gottlieb, Thomas, Gurguí, Mercè, Herrera, Fabián, Manzur, Adriana, Maschmeyer, Georg, Meije, Yolanda, Montejo, Miguel, Peghin, Maddalena, Rodríguez-Baño, Jesús, Ruiz-Camps, Isabel, Sukiennik, Teresa C., Tebe, Cristian, and Carratalà, Jordi

Abstract

ABSTRACTβ-Lactam/β-lactamase inhibitors (BLBLIs) were compared to carbapenems in two cohorts of hematological neutropenic patients with extended-spectrum-β-lactamase (ESBL) bloodstream infection (BSI): the empirical therapy cohort (174 patients) and the definitive therapy cohort (251 patients). The 30-day case fatality rates and other secondary outcomes were similar in the two therapy groups of the two cohorts and also in the propensity-matched cohorts. BLBLIs might be carbapenem-sparing alternatives for the treatment of BSI due to ESBLs in these patients.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results